or Try an Advanced Search...

    Technical Analysis for HLS - HLS Therapeutics Inc

    Grade Last Price % Change Price Change
    F 3.700 8.82% 0.300
    HLS closed up 2.1 percent on Wednesday, November 6, 2024, on 12 percent of normal volume.
    Earnings due: Nov 7
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical HLS trend table...
    Date Alert Name Type % Chg
    Outside Day Range Expansion 8.82%
    Gapped Up Strength 8.82%
    Up 3 Days in a Row Strength 8.82%
    NR7 Range Contraction 11.11%
    Narrow Range Bar Range Contraction 11.11%
    Lower Bollinger Band Walk Weakness 11.11%
    Lower Bollinger Band Walk Weakness 12.12%
    Lower Bollinger Band Touch Weakness 12.12%
    Lower Bollinger Band Walk Weakness 13.85%
    Gapped Up Strength 13.85%
    Older End-of-Day Signals for HLS ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 20 DMA about 2 hours ago
    Up 1 ATR about 2 hours ago
    Up 5% about 2 hours ago
    Rose Above 50 DMA about 3 hours ago
    Up 3% about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    HLS Chart by TradingView
    Basic chart:

    Profile

    HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Life Sciences Pharmaceutical Products

    Is HLS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.48
    52 Week Low 3.0
    Average Volume 24,033
    200-Day Moving Average 3.803
    50-Day Moving Average 3.506
    20-Day Moving Average 3.645
    10-Day Moving Average 3.434
    Average True Range 0.179
    RSI (14) 42.53
    ADX 36.84
    +DI 14.210
    -DI 36.126
    Chandelier Exit (Long, 3 ATRs) 3.465
    Chandelier Exit (Short, 3 ATRs) 3.536
    Upper Bollinger Bands 4.138
    Lower Bollinger Band 3.152
    Percent B (%b) 0.25
    BandWidth 27.029
    MACD Line -0.073
    MACD Signal Line -0.016
    MACD Histogram -0.0575
    Fundamentals Value
    Market Cap 108.2 Million
    Num Shares 31.8 Million
    EPS -0.90
    Price-to-Earnings (P/E) Ratio -3.79
    Price-to-Sales 8.55
    Price-to-Book 2.89
    Dividend 0.16
    Dividend Yield 4.71%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.685
    Resistance 3 (R3) 3.663 3.547 3.638
    Resistance 2 (R2) 3.547 3.474 3.558 3.622
    Resistance 1 (R1) 3.473 3.429 3.415 3.495 3.606
    Pivot Point 3.357 3.357 3.328 3.368 3.357
    Support 1 (S1) 3.283 3.284 3.225 3.305 3.194
    Support 2 (S2) 3.167 3.239 3.178 3.178
    Support 3 (S3) 3.093 3.167 3.163
    Support 4 (S4) 3.115